9145 Bevacizumab (B), cisplatin and vinorelbine in chemo-naive patients (P) with non squamous non small cell lung cancer (NSCLC): a galician lung cancer group phase II study

S.Vazquez; L.Leon; J.M.Gracia; J.Casal; M.Lazaro; J.L.Firvida; M.Amenedo; L.Santome; J.V.Cardona; S.Macia

首页> 外文期刊>European Journal of Cancer Supplements >9145 Bevacizumab (B), cisplatin and vinorelbine in chemo-naive patients (P) with non squamous non small cell lung cancer (NSCLC): a galician lung cancer group phase II study

【24h】

9145 Bevacizumab (B), cisplatin and vinorelbine in chemo-naive patients (P) with non squamous non small cell lung cancer (NSCLC): a galician lung cancer group phase II study

机译：9145 Bevacizumab（B），顺铂和长春瑞滨在初治非鳞状非小细胞肺癌（NSCLC）患者中的应用（P）：加利西亚肺癌组II期研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第2期|共2页
作者
S.Vazquez; L.Leon; J.M.Gracia; J.Casal; M.Lazaro; J.L.Firvida; M.Amenedo; L.Santome; J.V.Cardona; S.Macia;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC). [J] . Grigorescu A, Ciuleanu T, Firoiu E, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2007,第2期

机译：序贯性吉西他滨加长春瑞滨，吉西他滨加异环磷酰胺与吉西他滨加顺铂治疗II期和IV期非小细胞肺癌（NSCLC）初治患者的随机II期试验。
2. Switch maintenance treatment with oral vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer: a phase II study [J] . Petrioli Roberto, Francini Edoardo, Fiaschi Anna Ida, Medical oncology . 2015,第4期

机译：晚期非鳞状非小细胞肺癌患者顺铂，吉西他滨和贝伐单抗诱导化疗后口服长春瑞滨和贝伐单抗的维持治疗：II期研究
3. Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC) [J] . ReinmuthN., MeyerA., HartwigsenD., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2014,第3期

机译：随机，双盲II期研究比较了IIIB / IV期非小细胞肺癌（NSCLC）患者中的硝酸甘油加口服长春瑞滨加顺铂与单独口服长春瑞滨加顺铂的比较
4. Survival prediction of squamous cell head and neck cancer patients based on radiomic features selected from lung cancer patients using artificial neural network [C] . H. Kamezawa, H. Arimura, M. Soufi SPIE Medical Imaging Conference . 2018

机译：利用人工神经网络从肺癌患者的放射学特征中预测鳞状细胞癌的生存率
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP). [O] . E. Baldini, C. Tibaldi, A. Ardizzoni, 1998

机译：晚期非小细胞肺癌（NSCLC）患者的顺铂-长春地霉素-丝裂霉素（MVP）与顺铂-异环磷酰胺-长春瑞滨（PIN）与卡铂-长春瑞滨（CaN）：一项FONICAP随机II期研究。意大利肺癌工作组（FONICAP）。
7. P2-255: Gemcitabine and oral vinorelbine in elderly patients with advanced non–small cell lung cancer (NSCLC). A phase II study conducted by the Galician Lung Cancer Group (GLCG) [O] . Fírvida J.L., Vázquez S, Lázaro M, 2007

机译：P2-255：吉西他滨和长春瑞滨口服液用于老年晚期非小细胞肺癌（NSCLC）患者。加利西亚肺癌小组（GLCG）进行的II期研究

9145 Bevacizumab (B), cisplatin and vinorelbine in chemo-naive patients (P) with non squamous non small cell lung cancer (NSCLC): a galician lung cancer group phase II study

著录项

相似文献

相关主题

期刊订阅